Screening compound: InChI=1S/C21H17BrN6/c1-12-4-6-15(7-5-12)19-25-21-18-13(2)14(3)28(17-9-8-16(22)10-23-17)20(18)24-11-27(21)26-19/h4-11H,1-3H3

Screening compound: InChI=1S/C21H17BrN6/c1-12-4-6-15(7-5-12)19-25-21-18-13(2)14(3)28(17-9-8-16(22)10-23-17)20(18)24-11-27(21)26-19/h4-11H,1-3H3
Screening compound: InChI=1S/C21H17BrN6/c1-12-4-6-15(7-5-12)19-25-21-18-13(2)14(3)28(17-9-8-16(22)10-23-17)20(18)24-11-27(21)26-19/h4-11H,1-3H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C21H17BrN6/c1-12-4-6-15(7-5-12)19-25-21-18-13(2)14(3)28(17-9-8-16(22)10-23-17)20(18)24-11-27(21)26-19/h4-11H,1-3H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D472-0574

Molecular Formula

C21H17BrN6 (C21 H17 BrN6)

Compound Name

7-(5-bromo-2-pyridyl)-8,9-dimethyl-2-(4-methylphenyl)-7H-pyrrolo[3,2-e][1,2,4]triazolo[1,5-c]pyrimidine

IUPAC name

10-(5-bromopyridin-2-yl)-1112-dimethyl-4-(4-methylphenyl)-356810-pentaazatricyclo[7.3.0.0^{26}]dodeca-1(9)24711-pentaene

SMILES

Cc(c1c2ncn3nc(-c4ccc(C)cc4)nc13)c(C)n2-c(cc1)ncc1Br

InChI

InChI=1S/C21H17BrN6/c1-12-4-6-15(7-5-12)19-25-21-18-13(2)14(3)28(17-9-8-16(22)10-23-17)20(18)24-11-27(21)26-19/h4-11H,1-3H3

InChI Key

FTQLPUREZAIZIL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD18180657

InChI=1S/C21H17BrN6/c1-12-4-6-15(7-5-12)19-25-21-18-13(2)14(3)28(17-9-8-16(22)10-23-17)20(18)24-11-27(21)26-19/h4-11H,1-3H3 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Kinases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with InChI=1S/C21H17BrN6/c1-12-4-6-15(7-5-12)19-25-21-18-13(2)14(3)28(17-9-8-16(22)10-23-17)20(18)24-11-27(21)26-19/h4-11H,1-3H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C21H17BrN6/c1-12-4-6-15(7-5-12)19-25-21-18-13(2)14(3)28(17-9-8-16(22)10-23-17)20(18)24-11-27(21)26-19/h4-11H,1-3H3?
Check Price and Availability of InChI=1S/C21H17BrN6/c1-12-4-6-15(7-5-12)19-25-21-18-13(2)14(3)28(17-9-8-16(22)10-23-17)20(18)24-11-27(21)26-19/h4-11H,1-3H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C21H17BrN6/c1-12-4-6-15(7-5-12)19-25-21-18-13(2)14(3)28(17-9-8-16(22)10-23-17)20(18)24-11-27(21)26-19/h4-11H,1-3H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C21H17BrN6/c1-12-4-6-15(7-5-12)19-25-21-18-13(2)14(3)28(17-9-8-16(22)10-23-17)20(18)24-11-27(21)26-19/h4-11H,1-3H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C21H17BrN6/c1-12-4-6-15(7-5-12)19-25-21-18-13(2)14(3)28(17-9-8-16(22)10-23-17)20(18)24-11-27(21)26-19/h4-11H,1-3H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C21H17BrN6/c1-12-4-6-15(7-5-12)19-25-21-18-13(2)14(3)28(17-9-8-16(22)10-23-17)20(18)24-11-27(21)26-19/h4-11H,1-3H3 available by request